FivepHusion
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
34 Australia W, Austinmer, New South Wal...Website
www.fivephusion.comRevenue
<$5 MillionIndustry
About FivepHusion
FivepHusion is a private Australian biotechnology company focused on developing optimised cancer therapeutics, particularly a novel drug formulation called Deflexifol. This drug aims to enhance the safety and efficacy of standard cancer treatments, specifically targeting solid tumours such as colorectal, pancreatic, and breast cancers, as well as paediatric brain cancers. The company collaborates with the University of Wollongong for research and development, and its vision is to improve patient outcomes and quality of life through innovative cancer therapies. FivepHusion was founded in 2018 and is headquartered in New South Wales, Australia.Explore more
FivepHusion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to FivepHusion
Compare insights from companies similar to FivepHusion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FivepHusion Tech Stack
A closer look at the technologies used by FivepHusion
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding FivepHusion
Sign Up For FreeTo access detailed company insights
FivepHusion is a private Australian biotechnology company focused on developing optimised cancer therapeutics, particularly a novel drug formulation called Deflexifol. This drug aims to enhance the safety and efficacy of standard cancer treatments, specifically targeting solid tumours such as colorectal, pancreatic, and breast cancers, as well as p... Read More
